AIM ImmunoTech AIM
NYSE AIM
$0.17 -0.01 (-6.52%)
As of: Sep 29, 2026 · 3:59 PM EDT

AIM ImmunoTech (AIM) EBT Margin (2010 - 2026)

Updated

AIM ImmunoTech (AIM) recorded EBT Margin of -14646.15% in Q2 2026, down 3466.15 percentage points from -11180.00% a year earlier and down 3146.15 percentage points from the prior quarter.

Analysis

AIM ImmunoTech (AIM) EBT Margin (2010 - 2026) Analysis & Trends

On a TTM basis, AIM ImmunoTech's EBT Margin came in at -12922.11% as of Jun 30, 2026, up 1305.99 percentage points year-over-year; for FY2025, it was -14177.27%, down 2202.57 percentage points from FY2024.

  • Annual EBT Margin has a five-year change of -4431.87 percentage points (FY2020 to FY2025).
  • Across earlier years, EBT Margin came in at -11974.71% in FY2024 (+3825.29 pp), -15800.00% in FY2023 (-1670.21 pp), -14129.79% in FY2022 (-112.01 pp) and -14017.78% in FY2021 (-4272.38 pp).
  • Quarterly EBT Margin has ranged from -31052.38% in Q3 2022 to -7746.00% in Q2 2024 over the past five years.
  • On a year-over-year basis, EBT Margin rose in four of the last eight quarters, with an average year-over-year change of +1186.53 percentage points.
  • Peak year-over-year performance for EBT Margin in the last five years was a gain of 13319.77 percentage points in Q3 2023, against a drop of 19085.71 percentage points in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -11500.00% (Q1 2026), -15919.05% (Q4 2025) and -9980.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00 -14,646.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14,646.15%
Mar 31, 2026 -11,500.00%
Dec 31, 2025 -15,919.05%
Sep 30, 2025 -9,980.77%
Jun 30, 2025 -11,180.00%
Mar 31, 2025 -23,393.75%
Dec 31, 2024 -13,304.44%
Sep 30, 2024 -13,402.86%
Jun 30, 2024 -7,746.00%
Mar 31, 2024 -14,515.00%
Dec 31, 2023 -21,544.62%
Sep 30, 2023 -17,732.61%
Jun 30, 2023 -13,002.38%
Mar 31, 2023 -8,765.31%
Dec 31, 2022 -9,921.43%
Sep 30, 2022 -31,052.38%
Jun 30, 2022 -15,386.67%
Mar 31, 2022 -9,415.15%
Dec 31, 2021 -14,794.00%
Sep 30, 2021 -11,966.67%
API Access

AIM ImmunoTech EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=AIM&period=max&api_key=YOUR_API_KEY